AXGN
Price:
$14.205
Market Cap:
$622.60M
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attac...[Read more]
Industry
Medical - Devices
IPO Date
1986-12-17
Stock Exchange
NASDAQ
Ticker
AXGN
According to AxoGen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 666.44M. This represents a change of 97.51% compared to the average of 337.43M of the last 4 quarters.
The mean historical Enterprise Value of AxoGen, Inc. over the last ten years is 475.46M. The current 666.44M Enterprise Value has changed 13.92% with respect to the historical average. Over the past ten years (40 quarters), AXGN's Enterprise Value was at its highest in in the June 2018 quarter at 1.71B. The Enterprise Value was at its lowest in in the September 2014 quarter at 58.99M.
Average
475.46M
Median
446.51M
Minimum
80.49M
Maximum
931.17M
Discovering the peaks and valleys of AxoGen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 244.09%
Maximum Annual Enterprise Value = 931.17M
Minimum Annual Increase = -41.58%
Minimum Annual Enterprise Value = 80.49M
Year | Enterprise Value | Change |
---|---|---|
2023 | 325.13M | -31.14% |
2022 | 472.13M | 12.18% |
2021 | 420.88M | -41.58% |
2020 | 720.41M | 7.60% |
2019 | 669.52M | -8.82% |
2018 | 734.27M | -21.14% |
2017 | 931.17M | 244.09% |
2016 | 270.62M | 108.14% |
2015 | 130.02M | 61.53% |
2014 | 80.49M | 22.13% |
The current Enterprise Value of AxoGen, Inc. (AXGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
406.05M
5-year avg
521.61M
10-year avg
475.46M
AxoGen, Inc.’s Enterprise Value is greater than Anika Therapeutics, Inc. (191.10M), less than Orthofix Medical Inc. (791.72M), greater than Surmodics, Inc. (544.52M), greater than Paragon 28, Inc. (572.17M), less than Artivion, Inc. (1.46B), greater than Pulmonx Corporation (273.81M), greater than Electromed, Inc. (174.97M), less than RxSight, Inc. (2.03B), greater than Treace Medical Concepts, Inc. (392.16M), less than NuVasive, Inc. (2.91B), less than CONMED Corporation (3.08B), less than OrthoPediatrics Corp. (672.59M), greater than SI-BONE, Inc. (586.47M), less than Integer Holdings Corporation (5.29B), less than LivaNova PLC (2.98B),
Company | Enterprise Value | Market cap |
---|---|---|
191.10M | $253.47M | |
791.72M | $664.24M | |
544.52M | $535.37M | |
572.17M | $508.35M | |
1.46B | $1.15B | |
273.81M | $281.31M | |
174.97M | $190.96M | |
2.03B | $2.04B | |
392.16M | $340.49M | |
2.91B | $2.08B | |
3.08B | $2.18B | |
672.59M | $689.87M | |
586.47M | $572.04M | |
5.29B | $4.24B | |
2.98B | $2.65B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AxoGen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AxoGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AxoGen, Inc.'s Enterprise Value?
What is the highest Enterprise Value for AxoGen, Inc. (AXGN)?
What is the 3-year average Enterprise Value for AxoGen, Inc. (AXGN)?
What is the 5-year average Enterprise Value for AxoGen, Inc. (AXGN)?
How does the current Enterprise Value for AxoGen, Inc. (AXGN) compare to its historical average?